Abstract

BackgroundThe implementation of successful strategies to achieve an HIV cure has become a priority in HIV research. However, the current location and size of HIV reservoirs is still unknown since there are limited tools to evaluate HIV latency in viral sanctuaries such as gut-associated lymphoid tissue (GALT). As reported in the so called “Boston Patients”, despite undetectable levels of proviral HIV-1 DNA in blood and GALT, viral rebound happens in just few months after ART interruption. This fact might imply that current methods are not sensitive enough to detect residual reservoirs. Showing that, it is imperative to improve the detection and quantification of HIV-1 reservoir in tissue samples. Herein, we propose a novel non-enzymatic protocol for purification of Lamina Propria Leukocytes (LPL) from gut biopsies combined to viral HIV DNA (vDNA) quantification by droplet digital PCR (ddPCR) to improve the sensitivity and accuracy of viral reservoir measurements (LPL-vDNA assay).MethodsEndoscopic ileum biopsies were sampled from 12 HIV-1-infected cART-suppressed subjects. We performed a DTT/EDTA-based treatment for epithelial layer removal followed by non-enzymatic disruption of the tissue to obtain lamina propria cell suspension (LP). CD45+ cells were subsequently purified by flow sorting and vDNA was determined by ddPCR.ResultsvDNA quantification levels were significantly higher in purified LPLs (CD45+) than in bulk LPs (p<0.01). The levels of vDNA were higher in ileum samples than in concurrent PBMC from the same individuals (p = 0.002). As a result of the increased sensitivity of this purification method, the Poisson 95% confidence intervals of the vDNA quantification data from LPLs were narrower than that from bulk LPs. Of note, vDNA was unambiguously quantified above the detection limit in 100% of LPL samples, while only in 58% of bulk LPs.ConclusionWe propose an innovative combined protocol for a more sensitive detection of the HIV reservoir in gut-associated viral sanctuaries, which might be used to evaluate any proposed eradication strategy.

Highlights

  • There is an emerging interest in developing safe and affordable curative strategies that would eliminate the need for lifelong antiretroviral therapy (ART) in HIV-1 infected patients, improving the health status and reducing the risk of viral transmission to uninfected individuals

  • We performed a DTT/EDTA-based treatment for epithelial layer removal followed by non-enzymatic disruption of the tissue to obtain lamina propria cell suspension (LP)

  • Results viral HIV DNA (vDNA) quantification levels were significantly higher in purified Lamina Propria Leukocytes (LPL) (CD45+) than in bulk LPs (p

Read more

Summary

Introduction

There is an emerging interest in developing safe and affordable curative strategies that would eliminate the need for lifelong antiretroviral therapy (ART) in HIV-1 infected patients, improving the health status and reducing the risk of viral transmission to uninfected individuals. As reported in the so called “Boston Patients”, despite undetectable levels of proviral HIV-1 DNA in blood and GALT tissue, viral rebound can happen in just few months after ART recess [8]. This fact might imply that current methods are not sensitive enough to detect residual reservoirs, so new approaches are needed to better define and quantify HIV-1 reservoirs in tissue samples. As reported in the so called “Boston Patients”, despite undetectable levels of proviral HIV-1 DNA in blood and GALT, viral rebound happens in just few months after ART interruption This fact might imply that current methods are not sensitive enough to detect residual reservoirs. We propose a novel nonenzymatic protocol for purification of Lamina Propria Leukocytes (LPL) from gut biopsies combined to viral HIV DNA (vDNA) quantification by droplet digital PCR (ddPCR) to improve the sensitivity and accuracy of viral reservoir measurements (LPL-vDNA assay)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call